Search Within

Hans Guido Wendel

Formats
  1. Journal Article (63)
  2. Meeting Abstract (35)
  3. Research Letter (2)
  4. Editorial (1)
  5. Miscellaneous (1)
  6. Review (1)
Groups
  1. Cancer Biology and Genetics Program Faculty (103)
  2. GSK Faculty (103)
  3. Sloan Kettering Institute Faculty (103)
  4. Sloan Kettering Institute Postdocs (53)
  5. Department of Medicine (41)
  6. Hematologic Malignancies, Division of (31)

More Groups

People
  1. Man Jiang (20)
  2. Elisa De Stanchina (17)
  3. Kamini Man Singh (17)
  4. Konstantinos Mavrakis (13)
  5. Agnes Viale (12)
  6. Andrew Lerner Wolfe (12)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (7)
  4. 2022 (11)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Cancer Research (13)
  2. Blood (11)
  3. Cell Cycle (6)
  4. Proceedings of the National Academy of Sciences of the United States of America (6)
  5. Cancer Discovery (4)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Association for Cancer Research (26)
  2. American Society of Hematology (12)
  3. Nature Publishing Group (10)
  4. MDPI (6)
  5. National Academy of Sciences (6)
  6. Taylor & Francis Inc. (6)

More Publishers

Results (103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Coordinate translational control of KRAS signaling pathway in pancreatic adenocarcinoma
    Meeting Abstract

    Singh, K.; Wendel, H. G.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • KRAS and RAS signaling network is co-regulated and can be therapeutically blocked by targeting eIF4A dependent translation program
    Meeting Abstract

    Singh, K.; Lin, J.; Lecomte, N.; Mohan, P.; Gokce, A.; Sanghvi, V.; Olivera, G. H.; Jiang, M.; Burčul, A.; Stark, S.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • The immunoproteosome mediates resistance to natural killer cell killing
    Meeting Abstract

    Pasion, J.; Wendel, H. G.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Emerging therapeutic targets in follicular lymphoma [Interview]
    Miscellaneous

    Wendel, H. G.
    Clinical Advances in Hematology & Oncology (2020)

    Fulltext@MSK | Save
  • Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol
    Journal Article

    Müller, C.; Obermann, W.; Schulte, F. W.; Lange-Grünweller, K.; Oestereich, L.; Elgner, F.; Glitscher, M.; Hildt, E.; Singh, K.; Wendel, H. G.; more...
    Antiviral Research (2020)

    Fulltext@MSK | Save
  • O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth
    Journal Article

    Singh, J. P.; Qian, K.; Lee, J. S.; Zhou, J.; Han, X.; Zhang, B.; Ong, Q.; Ni, W.; Jiang, M.; Ruan, H. B.; more...
    Oncogene (2020)

    Fulltext@MSK | Save
  • Optimal dual-targeted CAR construct simultaneously targeting BCMA and GPRC5D prevents BCMA-escape driven relapse in multiple myeloma
    Meeting Abstract

    Fernandez de Larrea, C.; Staehr, M.; Lopez, A.; Chen, Y.; Purdon, T. J.; Ng, K. Y.; Wendel, H.; Brentjens, R. J.; Smith, E. L.
    Blood (2019)

    Fulltext@MSK | Save
  • eIF4A regulates ERK activation by controlling the translation of DUSP6
    Meeting Abstract

    Xu, J.; Wendel, H. G.; Pelletier, J.; Yao, Z.; Rosen, N.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • CAR-directed cytotoxicity of NK cells: An alternative tool to treat and to study multiple myeloma and NK biology
    Meeting Abstract

    Ng, K.; Pasion, J.; Wendel, H. G.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Noncovalent inhibitors reveal BTK gatekeeper and auto-inhibitory residues that control its transforming activity
    Journal Article

    Wang, S.; Mondal, S.; Zhao, C.; Berishaj, M.; Ghanakota, P.; Batlevi, C. L.; Dogan, A.; Seshan, V. E.; Abel, R.; Green, M. R.; more...
    JCI Insight (2019)

    Fulltext@MSK | Save